Cite
HARVARD Citation
Shukarev, G. et al. (2017). A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks. Human vaccines & immunotherapeutics. 13 (2), pp. 266-270. [Online].